Search through
Ezetimibe (CAS 163222-33-1) is a vital component in the US API intermediates market, where its role as a selective cholesterol absorption inhibitor necessitates Pharma/API purity of 99% to comply with stringent FDA cGMP standards and ensure optimal efficacy in lipid-regulating formulations. SCH 58235 has seen a surge in demand through custom synthesis services as North American pharmaceutical manufacturers increasingly prioritize domestic supply chain resilience and high purity fine chemicals to mitigate risks associated with global sourcing. Ezetrol serves as a cornerstone for any specialized bulk chemical supplier catering to the biopharmaceutical sector, where recent CDMO growth in the United States is driving the development of complex fixed-dose combination therapies for atherosclerosis and hyperlipidemia management. We are an established Ezetimibe api supplier with >= 99% purity for semi-finished formulators in the united states, providing comprehensive analytical (HPLC/NMR/MS) and supporting (Ezetimibe) COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities
Ezetimibe (CAS 163222-33-1) is a vital component in the US API intermediates market, where its role as a selective cholesterol absorption inhibitor necessitates Pharma/API purity of 99% to comply with stringent FDA cGMP standards and ensure optimal efficacy in lipid-regulating formulations. SCH 58235 has seen a surge in demand through custom synthesis services as North American pharmaceutical manufacturers increasingly prioritize domestic supply chain resilience and high purity fine chemicals to mitigate risks associated with global sourcing. Ezetrol serves as a cornerstone for any specialized bulk chemical supplier catering to the biopharmaceutical sector, where recent CDMO growth in the Un...
.3d8f8f41.svg)
Pharmaceutical
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Active Pharmaceutical Ingredients (APIs)
.7767eb0f.png)
Chemical Properties & Specifications
P201, P202, P260, P264, P270, P271, P273, P280, P301+P312, P330, P302+P352, P304+P340, P305+P351+P338, P308+P313, P321, P314, P362+P364, P332+P313, P337+P313, P391, P403+P233, P405, and P501
Acute Tox. 4 (100%)
Skin Irrit. 2 (100%)
A selective cholesterol-lowering medication used as monotherapy or in combination with statins to inhibit the Niemann-Pick C1-Like 1 (NPC1L1) protein at the brush border of the small intestine, thereby reducing the absorption of dietary and biliary cholesterol for the management of primary hyperlipidemia, homozygous familial hypercholesterolemia, and homozygous sitosterolemia.
Ezetimibe is a selective cholesterol absorption inhibitor used to treat high blood cholesterol by reducing the amount of cholesterol absorbed from food in the small intestine
This compound is primarily used in the pharmaceutical and healthcare industries for the production of lipid-lowering medications
It is available as oral tablets, often as monotherapy or in fixed-dose combinations with statins, and is practically insoluble in water but soluble in methanol, ethanol, and acetone
Standard analytical specifications include CAS number 163222-33-1, high purity (typically >=99%), and documentation such as COA, TDS, impurity reports (monitoring for desfluoro ezetimibe), and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
Category : Pharmaceutical Actives & Precursors
Sub-Category : Intermediates & Precursors
Description : P-Nitrobenzoyl Chloride (CAS 122-04-3) is a critical building block in the API intermediates market,...
